Table 1.
Demographic and clinical data of 36 HNSCC patients
Cancer origin | Oral cavity Larynx | 26 (72.2) 10 (27.8) |
||
Gender | Females | 14 (38.9) | ||
Male | 22 (61.1) | |||
Age at diagnosis, years | 58.8±13.1 | |||
Comorbidities | Comorbidities presence | 24 (66.7) | ||
No comorbidities | 12 (33.3) | |||
Smoking habit | Smoking | 14 (40) | ||
No smoking | 21 (60) | |||
Disease stage | Stage 1 | 3 (8.3) | ||
Stage 2 | 8 (22.2) | |||
Stage 3 | 3 (8.3) | |||
Stage 4 | 22 (61.1) | |||
OS | 82.9% (95% CI 67–94) | 76% (95% CI 56–91.3) | ||
DFS | 3-year survival | 82.2% (95% CI 66–94) | 5-year survival | 82.2% (95% CI 66–94) |
PFS | 59.4% (95% CI 40–77) | 59.4% (95% CI 40–77) |
Values are presented as n (%) or as indicated.